|
PABME 2009 will incorporate the already established PHARMA - part of the Arab Health portfolio since 2001.
 Meet and network with the leaders of the industry and potential investors in a “one stop shop” for all Pharmaceutical and Biotechnology professionals in the unique and futuristic city of Dubai, THE business hub of the Middle East!
The Middle East represents one of the largest pharmaceutical markets in the world with an estimated 12% Annual Compound Growth Rate. The pharmaceutical market is estimated to value $1.45 billion by 2012! With almost 90% of the branded products imported.
- The Ministry of Health alone has an annual budget of more than US $55million!
- With 2 freezones in Dubai alone to attract foreign investment, DubioTech and Dubai Healthcare City!
- The UAE tops the list of the Gulf and the other Arab countries in the individual consumption of medicines per year
The Middle East Biotechnology market is estimated at US $10 billion, with staggering growth of 15 – 18% per annum. Largest markets include Iran and Iraq at US $1 billion, Jordan at $US 900 million and Saudi Arabia US$ 700million, followed closely by Libya US $500, Yemen US $220 and a share by other countries.
- Several bio-technology parks are already being built here in the Middle East!
- Over 2000 visitors from 80 countries, attended PABME, responding enthusiastically to the unique East meets West Global showcase!
|